Cross Linked Hyaluronic Acid Sub Skin

Product Introduction：

The cross linked sodium hyaluronate gel has an excellent safety profile and is able to meet the therapeutic needs of different areas of the face. Single has excellent tissue integration and a more natural appearance; Double products have excellent lifting power, less pushing force, and more comfortable use. Crosslinker residue was not detected (detection limit 0.5μg/g), protein residue 3-5μg/g (detection limit 20μg/g), endomycin content was less than 0.5EU/mL. In addition, the unique micro-crosslinking technology produces a softer texture of the gel, which has a unique effect in the repair of light lines and is not easy to cause picucho. Excellent histocompatibility, more natural repair.

Product Display：

Product Details:

Product Package:

Customer Feedback:

Raw Material Advantages：

1.CLHA exhibits remarkable resistance to enzymatic degradation via hyaluronidases, prolonging its therapeutic effects up to 18-24 months in some formulations.

2.Advanced cross-linking technologies like 1,4-butanediol diglycidyl ether (BDDE) modification preserve HA's natural biocompatibility while improving mechanical stability.

Development Process:

Company Introduction:

1. As a pioneering high-tech enterprise founded in 2014, Jinan Grandwill Medical Technology delivers cutting-edge solutions across three core sectors: implantable biomaterials, medical devices, and aesthetic medicine. Our state-of-the-art production complex features advanced BFS blow-fill-seal technology and freeze-drying capabilities, validated through CE/FDA certifications. With 15 regulatory approvals including Class III absorbable hemostatic agents, we maintain 100% residual-free production through proprietary purification processes.